These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30815629)

  • 1. Sample sizes based on three popular indices of risks.
    Wang H; Wang B; Tu XM; Liu J; Feng C
    Gen Psychiatr; 2018; 31(3):e100011. PubMed ID: 30815629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size considerations in active-control non-inferiority trials with binary data based on the odds ratio.
    Siqueira AL; Todd S; Whitehead A
    Stat Methods Med Res; 2015 Aug; 24(4):453-61. PubMed ID: 24492793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size calculations with compliance information.
    Sato T
    Stat Med; 2000 Oct; 19(19):2689-97. PubMed ID: 10986542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relations among three popular indices of risks.
    Feng C; Wang B; Wang H
    Stat Med; 2019 Oct; 38(23):4772-4787. PubMed ID: 31338853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination for logistic regression revisited.
    Demidenko E
    Stat Med; 2007 Aug; 26(18):3385-97. PubMed ID: 17149799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical assessment of biosimilarity based on the relative distance between follow-on biologics for binary endpoints.
    Shin W; Kang SH
    J Biopharm Stat; 2016; 26(2):227-39. PubMed ID: 25372220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A myriad of methods: calculated sample size for two proportions was dependent on the choice of sample size formula and software.
    Bell ML; Teixeira-Pinto A; McKenzie JE; Olivier J
    J Clin Epidemiol; 2014 May; 67(5):601-5. PubMed ID: 24439070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing sample size formulae for trials with unbalanced allocation using the logrank test.
    Hsieh FY
    Stat Med; 1992 Jun; 11(8):1091-8. PubMed ID: 1496196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample Size Calculations for Combination Drugs of 2 Monotherapies With a Single Approved Dose Level: Binary Endpoint Cases.
    Kang SH; Park J
    Ther Innov Regul Sci; 2017 Mar; 51(2):181-189. PubMed ID: 30231730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problem of therapeutic efficacy indices. 2. Description of the indices].
    Boissel JP; Buyse M; Cucherat M; Boutitie F; Gueyffier F; Chatellier G; Li W; Nony P; Haugh M; Mignot G
    Therapie; 1999; 54(3):309-14. PubMed ID: 10500443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes.
    You Z; Williams OD; Aban I; Kabagambe EK; Tiwari HK; Cutter G
    Clin Trials; 2011 Feb; 8(1):27-36. PubMed ID: 21163852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination in stratified trials to establish the equivalence of two treatments.
    Nam JM
    Stat Med; 1995 Sep; 14(18):2037-49. PubMed ID: 8677403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample Size Calculations for Time-Averaged Difference of Longitudinal Binary Outcomes.
    Lou Y; Cao J; Zhang S; Ahn C
    Commun Stat Theory Methods; 2017; 46(1):344-353. PubMed ID: 28603337
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.